New analysis shows tirzepatide consistently reduces body weight regardless of body mass index (BMI) before treatment
Tirzepatide, a medication authorized to treat obesity and/or type 2 diabetes, consistently reduces bodyweight regardless of the patient’s body mass index (BMI before treatment), from the range of overweight to class III obesity.
Facebook Comments
https://www.sarkaridoctor.com/wp-content/uploads/2022/01/logo@2xx.png00aajahttps://www.sarkaridoctor.com/wp-content/uploads/2022/01/logo@2xx.pngaaja2024-03-14 12:00:162024-03-14 12:00:16New analysis shows tirzepatide consistently reduces body weight regardless of body mass index (BMI) before treatment
